Pharmaceutical Tracing for Manufacturers
We work with manufacturers to ensure the accurate exchange of drug transaction data to avoid service interruption.
Cardinal Health has adopted a standard systematic approach for accepting transaction data – information, history, statement – from manufacturers.
To ensure accuracy and efficiency, Cardinal Health expects manufacturers to send transaction data in electronic format. We believe that the Advance Ship Notices (ASNs), which are electronic documents transmitted via EDI, provide the most direct path to electronic transmission of the required data.
Manufacturers can learn more about their responsibilities and working with Cardinal Health by joining the Cardinal Health DSCSA Forum the first Monday of every month at 1:00 p.m. eastern. Dial-in, 855.241.2663; Conference ID, 3863795.
Information and resources:
Manufacturer
HDA standard product information form (rev Feb 2017)
Transaction data elements & requirements
Manufacturer reference manual
Communications
Cardinal Health important DSCSA update - April 14, 2020
Cardinal Health DSCSA Supplier Letter and Survey - July 2019
Cardinal Health DSCSA Requirements and
GTIN Master Data - 2018
Cardinal Health DSCSA expectations
for manufacturers-2017
Cardinal Health DSCSA expectations
for manufacturers-2016
Cardinal Health perspectives on DSCSA - HDMA presentation
Drug Supply Chain Security Act requirements
Technical
EPCIS Onboarding Guide for DSCSA v 5.3
HDA Barcode Guidelines - Revised November 2017
GS1 implementation guide v 1.1
GS1 implementation guide v 1.2
GS1 FAQs by the pharma industry preparing for DSCSA
HDA guidelines for ASN 856